CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net income attributable to Honeywell	$ 2,675,000,000	$ 2,377,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:
Depreciation and amortization	681,000,000	704,000,000
Gain on sale of nonstrategic businesses and assets	(3,000,000)	(353,000,000)
Repositioning and other charges	356,000,000	637,000,000
Net payments for repositioning and other charges	(352,000,000)	(335,000,000)
Pension and other postretirement expense	81,000,000	(24,000,000)
Pension and other postretirement benefit payments	(888,000,000)	(1,568,000,000)
Stock compensation expense	131,000,000	129,000,000
Deferred income taxes	319,000,000	197,000,000
Excess tax benefits from share based payment arrangements	(28,000,000)	(31,000,000)
Other	39,000,000	56,000,000
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:
Accounts, notes and other receivables	(160,000,000)	(433,000,000)
Inventories	(53,000,000)	(440,000,000)
Other current assets	(77,000,000)	(53,000,000)
Accounts payable	(220,000,000)	365,000,000
Accrued liabilities	(333,000,000)	128,000,000
Net cash provided by operating activities	2,168,000,000	1,356,000,000
Cash flows from investing activities:
Expenditures for property, plant and equipment	(586,000,000)	(466,000,000)
Proceeds from disposals of property, plant and equipment	2,000,000	3,000,000
Increase in investments	(482,000,000)	(322,000,000)
Decrease in investments	287,000,000	288,000,000
Cash paid for acquisitions, net of cash acquired	(62,000,000)	(627,000,000)
Proceeds from sales of businesses, net of fees paid	18,000,000	1,170,000,000
Other	(42,000,000)	67,000,000
Net cash (used for)/provided by investing activities	(865,000,000)	113,000,000
Cash flows from financing activities:
Net increase in commercial paper	300,000,000	401,000,000
Net increase/(decrease) in short-term borrowings	19,000,000	(4,000,000)
Proceeds from issuance of common stock	179,000,000	232,000,000
Proceeds from issuance of long-term debt	86,000,000	1,389,000,000
Payments of long-term debt	0	(439,000,000)
Excess tax benefits from share based payment arrangements	28,000,000	31,000,000
Repurchases of common stock	0	(1,009,000,000)
Cash dividends paid	(880,000,000)	(796,000,000)
Net cash used for financing activities	(268,000,000)	(195,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents	27,000,000	(39,000,000)
Net increase in cash and cash equivalents	1,062,000,000	1,235,000,000
Cash and cash equivalents at beginning of period	3,698,000,000	2,650,000,000
Cash and cash equivalents at end of period	$ 4,760,000,000	$ 3,885,000,000